Cibc Private Wealth Group, LLC Neogenomics Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,320 shares of NEO stock, worth $23,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,320
Previous 3,764
11.8%
Holding current value
$23,671
Previous $62,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$47.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$43.1 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$40.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $897M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...